Brief: Corline Biomedical's Rights Issue Oversubscribed By 352%
Jan 27 (Reuters) - Corline Biomedical AB CLBIO.ST :
* SAID ON TUESDAY RIGHTS ISSUE OVERSUBSCRIBED BY 342%
* RIGHTS ISSUE IS FULLY SUBSCRIBED AND PROVIDES CORLINE WITH
ABOUT
SEK 15 MLN BEFORE ISSUE COSTS
Source text for Eikon: urn:newsml:reuters.com:*:nGNE8nVBBb
Further company coverage: CLBIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln